Insider Buying: The Rain Therapeutics Inc. (NASDAQ:RAIN) Co-Founder Just Bought US$57k Worth Of Shares
yahoo.com
news
2022-06-05 12:16:00

Even if it's not a huge purchase, we think it was good to see that Avanish Vellanki, the Co-Founder of Rain Therapeutics Inc. (NASDAQ:RAIN) recently shelled out US$57k to buy stock, at US$2.29 per share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

View our latest analysis for Rain Therapeutics

Rain Therapeutics Insider Transactions Over The Last Year

Notably, that recent purchase by Avanish Vellanki is the biggest insider purchase of Rain Therapeutics shares that we've seen in the last year.
